Domov › Nemalicelični pljučni rak › Iowa › Cedar Rapids
Klinične študije za Nemalicelični pljučni rak v Cedar Rapids, IA
20 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Cedar Rapids in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Vključevanje udeležencevFaza 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Vključevanje udeležencevFaza 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Vključevanje udeležencevFaza 3
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi stran
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Local Institution - 0065, Iowa City · 25 mi stran
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Vključevanje udeležencevFaza 3
- Mercy Medical Center, Cedar Rapids
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Vključevanje udeležencevFaza 2/3
- Physicians Clinic of Iowa, Cedar Rapids
- Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City · 25 mi stran
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Vključevanje udeležencevFaza 1
- University of Iowa Hospital and Clinics, Iowa City · 25 mi stran
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Vključevanje udeležencevFaza 1
- University of Iowa, Iowa City · 25 mi stran
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- University of Iowa, Iowa City · 25 mi stran
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Vključevanje udeležencevFaza 1/2
- University of Iowa Hospitals & Clinics PARENT, Iowa City · 25 mi stran
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of Iowa, Iowa City · 25 mi stran
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- University of Iowa, Iowa City · 25 mi stran
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Vključevanje udeležencevFaza 1
- University of Iowa Health Care, Iowa City · 25 mi stran
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi stran
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Vključevanje udeležencevFaza 2
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi stran
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Vključevanje udeležencevOpazovalna študija
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi stran
GEMINI-NSCLC: NSCLC Biomarker Study
Vključevanje udeležencevOpazovalna študija
- University of Iowa, Iowa City · 25 mi stran
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Iowa City · 25 mi stran
Test-retest Evaluation of [18F]F-AraG PET
Vključevanje udeležencevFaza 2
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi stran
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY121 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH57 študij
- Washington, DC55 študij
Druge študije v Cedar Rapids
- Rak dojke17 študij
- Rak (vse vrste)16 študij
- Akutna mieločna levkemija16 študij
- Množni mielom15 študij
- Rak pljuč14 študij
- Kolorektalni rak13 študij
- Ploščatocelični karcinom glave in vratu12 študij
- Rak prostate12 študij
- Možganska kap10 študij
- Melanom10 študij
- Rak endometrija9 študij
- Rak krvi9 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.